A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, California

Author:

Wagner John A.12,Moran Mary Lynn3,Messner Anna H.4,Daifuku Richard5,Conrad Carol K.6,Reynolds Thomas5,Guggino William B.7,Moss Richard B.6,Carter Barrie J.5,Wine Jeffrey J.8,Flotte Terence R.9,Gardner Phyllis12

Affiliation:

1. Department of Molecular Pharmacology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5332.

2. Division of Clinical Pharmacology, Department of Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305.

3. 2200 Sand Hill Road, Suite 120, Menlo Park, CA.

4. Division of Otolaryngology, Department of Surgery, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305.

5. Targeted Genetics Corporation, 1100 Olive Way, Suite 100, Seattle, WA 98101.

6. Division of Allergy-Pulmonary, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305.

7. Department of Physiology and Pediatrics, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205.

8. Cystic Fibrosis Research Lab, Department of Psychology, Stanford University, Stanford, CA 94305-2130.

9. Departments of Pediatrics, Molecular Genetics, Microbiology and the Gene Therapy Center, University of Florida, Gainesville, FL 32610.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Gene Therapy and Cardiovascular Diseases;Advances in Experimental Medicine and Biology;2022-12-02

2. Non-Modulator Therapies;Clinics in Chest Medicine;2022-12

3. Medical interventions for chronic rhinosinusitis in cystic fibrosis;Cochrane Database of Systematic Reviews;2022-04-07

4. Gene Therapy: A Possible Alternative to CFTR Modulators?;Frontiers in Pharmacology;2021-04-21

5. Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF;Pediatric Pulmonology;2021-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3